QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study
Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Ito, Yuichi [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Gastric Cancer - Springer-Verlag, 2002, 24(2021), 5 vom: 31. März, Seite 1131-1139 |
|---|---|
| Übergeordnetes Werk: |
volume:24 ; year:2021 ; number:5 ; day:31 ; month:03 ; pages:1131-1139 |
| Links: |
|---|
| DOI / URN: |
10.1007/s10120-021-01179-4 |
|---|
| Katalog-ID: |
SPR044740417 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR044740417 | ||
| 003 | DE-627 | ||
| 005 | 20230507143945.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210805s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10120-021-01179-4 |2 doi | |
| 035 | |a (DE-627)SPR044740417 | ||
| 035 | |a (SPR)s10120-021-01179-4-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ito, Yuichi |e verfasserin |0 (orcid)0000-0003-4692-3110 |4 aut | |
| 245 | 1 | 0 | |a QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 | ||
| 520 | |a Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate. | ||
| 650 | 4 | |a Palliative surgery |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Malignant bowel obstruction |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Peritoneal dissemination |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Gastric cancer |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Quality of life |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Prospective multicenter observational study |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Fujitani, Kazumasa |4 aut | |
| 700 | 1 | |a Sakamaki, Kentaro |4 aut | |
| 700 | 1 | |a Ando, Masahiko |4 aut | |
| 700 | 1 | |a Kawabata, Ryohei |4 aut | |
| 700 | 1 | |a Tanizawa, Yutaka |4 aut | |
| 700 | 1 | |a Yoshikawa, Takaki |4 aut | |
| 700 | 1 | |a Yamada, Takanobu |4 aut | |
| 700 | 1 | |a Hirao, Motohiro |4 aut | |
| 700 | 1 | |a Yamada, Makoto |4 aut | |
| 700 | 1 | |a Hihara, Jun |4 aut | |
| 700 | 1 | |a Fukushima, Ryoji |4 aut | |
| 700 | 1 | |a Choda, Yasuhiro |4 aut | |
| 700 | 1 | |a Kodera, Yasuhiro |4 aut | |
| 700 | 1 | |a Teshima, Shin |4 aut | |
| 700 | 1 | |a Shinohara, Hisashi |4 aut | |
| 700 | 1 | |a Kondo, Masato |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gastric Cancer |d Springer-Verlag, 2002 |g 24(2021), 5 vom: 31. März, Seite 1131-1139 |w (DE-627)SPR009286586 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2021 |g number:5 |g day:31 |g month:03 |g pages:1131-1139 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10120-021-01179-4 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2021 |e 5 |b 31 |c 03 |h 1131-1139 | ||
| author_variant |
y i yi k f kf k s ks m a ma r k rk y t yt t y ty t y ty m h mh m y my j h jh r f rf y c yc y k yk s t st h s hs m k mk |
|---|---|
| matchkey_str |
itoyuichifujitanikazumasasakamakikentaro:2021----:oassmnatralaieugrfrainnbwlbtutocuebprtnadseiainfaticnea |
| hierarchy_sort_str |
2021 |
| publishDate |
2021 |
| allfields |
10.1007/s10120-021-01179-4 doi (DE-627)SPR044740417 (SPR)s10120-021-01179-4-e DE-627 ger DE-627 rakwb eng Ito, Yuichi verfasserin (orcid)0000-0003-4692-3110 aut QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate. Palliative surgery (dpeaa)DE-He213 Malignant bowel obstruction (dpeaa)DE-He213 Peritoneal dissemination (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Prospective multicenter observational study (dpeaa)DE-He213 Fujitani, Kazumasa aut Sakamaki, Kentaro aut Ando, Masahiko aut Kawabata, Ryohei aut Tanizawa, Yutaka aut Yoshikawa, Takaki aut Yamada, Takanobu aut Hirao, Motohiro aut Yamada, Makoto aut Hihara, Jun aut Fukushima, Ryoji aut Choda, Yasuhiro aut Kodera, Yasuhiro aut Teshima, Shin aut Shinohara, Hisashi aut Kondo, Masato aut Enthalten in Gastric Cancer Springer-Verlag, 2002 24(2021), 5 vom: 31. März, Seite 1131-1139 (DE-627)SPR009286586 nnns volume:24 year:2021 number:5 day:31 month:03 pages:1131-1139 https://dx.doi.org/10.1007/s10120-021-01179-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 24 2021 5 31 03 1131-1139 |
| spelling |
10.1007/s10120-021-01179-4 doi (DE-627)SPR044740417 (SPR)s10120-021-01179-4-e DE-627 ger DE-627 rakwb eng Ito, Yuichi verfasserin (orcid)0000-0003-4692-3110 aut QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate. Palliative surgery (dpeaa)DE-He213 Malignant bowel obstruction (dpeaa)DE-He213 Peritoneal dissemination (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Prospective multicenter observational study (dpeaa)DE-He213 Fujitani, Kazumasa aut Sakamaki, Kentaro aut Ando, Masahiko aut Kawabata, Ryohei aut Tanizawa, Yutaka aut Yoshikawa, Takaki aut Yamada, Takanobu aut Hirao, Motohiro aut Yamada, Makoto aut Hihara, Jun aut Fukushima, Ryoji aut Choda, Yasuhiro aut Kodera, Yasuhiro aut Teshima, Shin aut Shinohara, Hisashi aut Kondo, Masato aut Enthalten in Gastric Cancer Springer-Verlag, 2002 24(2021), 5 vom: 31. März, Seite 1131-1139 (DE-627)SPR009286586 nnns volume:24 year:2021 number:5 day:31 month:03 pages:1131-1139 https://dx.doi.org/10.1007/s10120-021-01179-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 24 2021 5 31 03 1131-1139 |
| allfields_unstemmed |
10.1007/s10120-021-01179-4 doi (DE-627)SPR044740417 (SPR)s10120-021-01179-4-e DE-627 ger DE-627 rakwb eng Ito, Yuichi verfasserin (orcid)0000-0003-4692-3110 aut QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate. Palliative surgery (dpeaa)DE-He213 Malignant bowel obstruction (dpeaa)DE-He213 Peritoneal dissemination (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Prospective multicenter observational study (dpeaa)DE-He213 Fujitani, Kazumasa aut Sakamaki, Kentaro aut Ando, Masahiko aut Kawabata, Ryohei aut Tanizawa, Yutaka aut Yoshikawa, Takaki aut Yamada, Takanobu aut Hirao, Motohiro aut Yamada, Makoto aut Hihara, Jun aut Fukushima, Ryoji aut Choda, Yasuhiro aut Kodera, Yasuhiro aut Teshima, Shin aut Shinohara, Hisashi aut Kondo, Masato aut Enthalten in Gastric Cancer Springer-Verlag, 2002 24(2021), 5 vom: 31. März, Seite 1131-1139 (DE-627)SPR009286586 nnns volume:24 year:2021 number:5 day:31 month:03 pages:1131-1139 https://dx.doi.org/10.1007/s10120-021-01179-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 24 2021 5 31 03 1131-1139 |
| allfieldsGer |
10.1007/s10120-021-01179-4 doi (DE-627)SPR044740417 (SPR)s10120-021-01179-4-e DE-627 ger DE-627 rakwb eng Ito, Yuichi verfasserin (orcid)0000-0003-4692-3110 aut QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate. Palliative surgery (dpeaa)DE-He213 Malignant bowel obstruction (dpeaa)DE-He213 Peritoneal dissemination (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Prospective multicenter observational study (dpeaa)DE-He213 Fujitani, Kazumasa aut Sakamaki, Kentaro aut Ando, Masahiko aut Kawabata, Ryohei aut Tanizawa, Yutaka aut Yoshikawa, Takaki aut Yamada, Takanobu aut Hirao, Motohiro aut Yamada, Makoto aut Hihara, Jun aut Fukushima, Ryoji aut Choda, Yasuhiro aut Kodera, Yasuhiro aut Teshima, Shin aut Shinohara, Hisashi aut Kondo, Masato aut Enthalten in Gastric Cancer Springer-Verlag, 2002 24(2021), 5 vom: 31. März, Seite 1131-1139 (DE-627)SPR009286586 nnns volume:24 year:2021 number:5 day:31 month:03 pages:1131-1139 https://dx.doi.org/10.1007/s10120-021-01179-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 24 2021 5 31 03 1131-1139 |
| allfieldsSound |
10.1007/s10120-021-01179-4 doi (DE-627)SPR044740417 (SPR)s10120-021-01179-4-e DE-627 ger DE-627 rakwb eng Ito, Yuichi verfasserin (orcid)0000-0003-4692-3110 aut QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate. Palliative surgery (dpeaa)DE-He213 Malignant bowel obstruction (dpeaa)DE-He213 Peritoneal dissemination (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Prospective multicenter observational study (dpeaa)DE-He213 Fujitani, Kazumasa aut Sakamaki, Kentaro aut Ando, Masahiko aut Kawabata, Ryohei aut Tanizawa, Yutaka aut Yoshikawa, Takaki aut Yamada, Takanobu aut Hirao, Motohiro aut Yamada, Makoto aut Hihara, Jun aut Fukushima, Ryoji aut Choda, Yasuhiro aut Kodera, Yasuhiro aut Teshima, Shin aut Shinohara, Hisashi aut Kondo, Masato aut Enthalten in Gastric Cancer Springer-Verlag, 2002 24(2021), 5 vom: 31. März, Seite 1131-1139 (DE-627)SPR009286586 nnns volume:24 year:2021 number:5 day:31 month:03 pages:1131-1139 https://dx.doi.org/10.1007/s10120-021-01179-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 24 2021 5 31 03 1131-1139 |
| language |
English |
| source |
Enthalten in Gastric Cancer 24(2021), 5 vom: 31. März, Seite 1131-1139 volume:24 year:2021 number:5 day:31 month:03 pages:1131-1139 |
| sourceStr |
Enthalten in Gastric Cancer 24(2021), 5 vom: 31. März, Seite 1131-1139 volume:24 year:2021 number:5 day:31 month:03 pages:1131-1139 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Palliative surgery Malignant bowel obstruction Peritoneal dissemination Gastric cancer Quality of life Prospective multicenter observational study |
| isfreeaccess_bool |
false |
| container_title |
Gastric Cancer |
| authorswithroles_txt_mv |
Ito, Yuichi @@aut@@ Fujitani, Kazumasa @@aut@@ Sakamaki, Kentaro @@aut@@ Ando, Masahiko @@aut@@ Kawabata, Ryohei @@aut@@ Tanizawa, Yutaka @@aut@@ Yoshikawa, Takaki @@aut@@ Yamada, Takanobu @@aut@@ Hirao, Motohiro @@aut@@ Yamada, Makoto @@aut@@ Hihara, Jun @@aut@@ Fukushima, Ryoji @@aut@@ Choda, Yasuhiro @@aut@@ Kodera, Yasuhiro @@aut@@ Teshima, Shin @@aut@@ Shinohara, Hisashi @@aut@@ Kondo, Masato @@aut@@ |
| publishDateDaySort_date |
2021-03-31T00:00:00Z |
| hierarchy_top_id |
SPR009286586 |
| id |
SPR044740417 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR044740417</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230507143945.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210805s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s10120-021-01179-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR044740417</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s10120-021-01179-4-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ito, Yuichi</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0003-4692-3110</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Palliative surgery</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Malignant bowel obstruction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peritoneal dissemination</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastric cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality of life</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prospective multicenter observational study</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fujitani, Kazumasa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakamaki, Kentaro</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ando, Masahiko</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kawabata, Ryohei</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tanizawa, Yutaka</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yoshikawa, Takaki</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Takanobu</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hirao, Motohiro</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Makoto</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hihara, Jun</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fukushima, Ryoji</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Choda, Yasuhiro</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kodera, Yasuhiro</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teshima, Shin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shinohara, Hisashi</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kondo, Masato</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Gastric Cancer</subfield><subfield code="d">Springer-Verlag, 2002</subfield><subfield code="g">24(2021), 5 vom: 31. März, Seite 1131-1139</subfield><subfield code="w">(DE-627)SPR009286586</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:24</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:5</subfield><subfield code="g">day:31</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:1131-1139</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s10120-021-01179-4</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">24</subfield><subfield code="j">2021</subfield><subfield code="e">5</subfield><subfield code="b">31</subfield><subfield code="c">03</subfield><subfield code="h">1131-1139</subfield></datafield></record></collection>
|
| author |
Ito, Yuichi |
| spellingShingle |
Ito, Yuichi misc Palliative surgery misc Malignant bowel obstruction misc Peritoneal dissemination misc Gastric cancer misc Quality of life misc Prospective multicenter observational study QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study |
| authorStr |
Ito, Yuichi |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR009286586 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study Palliative surgery (dpeaa)DE-He213 Malignant bowel obstruction (dpeaa)DE-He213 Peritoneal dissemination (dpeaa)DE-He213 Gastric cancer (dpeaa)DE-He213 Quality of life (dpeaa)DE-He213 Prospective multicenter observational study (dpeaa)DE-He213 |
| topic |
misc Palliative surgery misc Malignant bowel obstruction misc Peritoneal dissemination misc Gastric cancer misc Quality of life misc Prospective multicenter observational study |
| topic_unstemmed |
misc Palliative surgery misc Malignant bowel obstruction misc Peritoneal dissemination misc Gastric cancer misc Quality of life misc Prospective multicenter observational study |
| topic_browse |
misc Palliative surgery misc Malignant bowel obstruction misc Peritoneal dissemination misc Gastric cancer misc Quality of life misc Prospective multicenter observational study |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Gastric Cancer |
| hierarchy_parent_id |
SPR009286586 |
| hierarchy_top_title |
Gastric Cancer |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR009286586 |
| title |
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study |
| ctrlnum |
(DE-627)SPR044740417 (SPR)s10120-021-01179-4-e |
| title_full |
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study |
| author_sort |
Ito, Yuichi |
| journal |
Gastric Cancer |
| journalStr |
Gastric Cancer |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
txt |
| container_start_page |
1131 |
| author_browse |
Ito, Yuichi Fujitani, Kazumasa Sakamaki, Kentaro Ando, Masahiko Kawabata, Ryohei Tanizawa, Yutaka Yoshikawa, Takaki Yamada, Takanobu Hirao, Motohiro Yamada, Makoto Hihara, Jun Fukushima, Ryoji Choda, Yasuhiro Kodera, Yasuhiro Teshima, Shin Shinohara, Hisashi Kondo, Masato |
| container_volume |
24 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Ito, Yuichi |
| doi_str_mv |
10.1007/s10120-021-01179-4 |
| normlink |
(ORCID)0000-0003-4692-3110 |
| normlink_prefix_str_mv |
(orcid)0000-0003-4692-3110 |
| title_sort |
qol assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study |
| title_auth |
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study |
| abstract |
Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate. © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 |
| abstractGer |
Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate. © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 |
| abstract_unstemmed |
Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate. © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER |
| container_issue |
5 |
| title_short |
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study |
| url |
https://dx.doi.org/10.1007/s10120-021-01179-4 |
| remote_bool |
true |
| author2 |
Fujitani, Kazumasa Sakamaki, Kentaro Ando, Masahiko Kawabata, Ryohei Tanizawa, Yutaka Yoshikawa, Takaki Yamada, Takanobu Hirao, Motohiro Yamada, Makoto Hihara, Jun Fukushima, Ryoji Choda, Yasuhiro Kodera, Yasuhiro Teshima, Shin Shinohara, Hisashi Kondo, Masato |
| author2Str |
Fujitani, Kazumasa Sakamaki, Kentaro Ando, Masahiko Kawabata, Ryohei Tanizawa, Yutaka Yoshikawa, Takaki Yamada, Takanobu Hirao, Motohiro Yamada, Makoto Hihara, Jun Fukushima, Ryoji Choda, Yasuhiro Kodera, Yasuhiro Teshima, Shin Shinohara, Hisashi Kondo, Masato |
| ppnlink |
SPR009286586 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s10120-021-01179-4 |
| up_date |
2024-07-04T02:08:33.084Z |
| _version_ |
1803612494849114112 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR044740417</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230507143945.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210805s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s10120-021-01179-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR044740417</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s10120-021-01179-4-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ito, Yuichi</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0003-4692-3110</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2021</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Patients with peritoneal dissemination of gastric cancer have poor oral intake caused by malignant bowel obstruction (MBO). Palliative surgery has often been undertaken to improve quality of life (QOL), but few prospective studies on palliative surgery in this patient population have been published. Patients and methods We prospectively investigated the significance of palliative surgery using patient-reported QOL measures. Patients underwent palliative surgery by small intestine/colon resection or small intestine/colon bypass or ileostomy/colostomy for MBO. The primary endpoint was change in QOL assessed at baseline, 14 days, 1 month, and 3 months following palliative surgery using the Euro QoL Five Dimensions (EQ-5D™) questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire gastric cancer module (QLQ-STO22). Secondary endpoints were postoperative improvement in oral intake and surgical complications. Results Between April 2013 and March 2018, 63 patients were enrolled from 14 institutions. The mean EQ-5D™ utility index baseline score of 0.6 remained consistent. Gastric-specific symptoms mostly showed statistically significant improvement from baseline. Forty-two patients (67%) were able to eat solid food 2 weeks after palliative surgery and 36 patients (57%) tolerated it for 3 months. The rate of overall morbidity of ≥ grade III according to the Clavien–Dindo classification was 16% (10 patients) and the 30-day postoperative mortality rate was 3.2% (2 patients). Conclusions In patients with MBO caused by peritoneal dissemination of gastric cancer, palliative surgery did not improve QOL while improving solid food intake, with an acceptable postoperative morbidity and mortality rate.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Palliative surgery</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Malignant bowel obstruction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peritoneal dissemination</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastric cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality of life</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prospective multicenter observational study</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fujitani, Kazumasa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakamaki, Kentaro</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ando, Masahiko</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kawabata, Ryohei</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tanizawa, Yutaka</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yoshikawa, Takaki</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Takanobu</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hirao, Motohiro</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamada, Makoto</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hihara, Jun</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fukushima, Ryoji</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Choda, Yasuhiro</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kodera, Yasuhiro</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teshima, Shin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shinohara, Hisashi</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kondo, Masato</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Gastric Cancer</subfield><subfield code="d">Springer-Verlag, 2002</subfield><subfield code="g">24(2021), 5 vom: 31. März, Seite 1131-1139</subfield><subfield code="w">(DE-627)SPR009286586</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:24</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:5</subfield><subfield code="g">day:31</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:1131-1139</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s10120-021-01179-4</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">24</subfield><subfield code="j">2021</subfield><subfield code="e">5</subfield><subfield code="b">31</subfield><subfield code="c">03</subfield><subfield code="h">1131-1139</subfield></datafield></record></collection>
|
| score |
7.399803 |